Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.

Autor: Mittal P; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Department of Haematology, Cancer Institute, University College London, London, United Kingdom., Gafoor R; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Sayar Z; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Department of Haematology, Whittington Health NHS Trust, London, United Kingdom., Efthymiou M; Department of Haematology, Cancer Institute, University College London, London, United Kingdom., Tohidi-Esfahani I; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Department of Haematology, Cancer Institute, University College London, London, United Kingdom., Appiah-Cubi S; Department of Haematology, Epsom and St Heliers University Hospitals NHS Trust, Epsom, United Kingdom., Arachchillage DJ; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom., Atkinson D; Centre for Medical Imaging, Division of Medicine, University College London, London, United Kingdom., Bordea E; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Cardoso MJ; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom., Caverly E; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Chandratheva A; Stroke Research Centre, University College London Queen Square Institute of Neurology, London, United Kingdom.; Comprehensive Stroke Service, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Chau M; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Freemantle N; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Gates C; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Ja Ger HR; Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, University College London Institute of Neurology, London, United Kingdom., Kaul A; Department of Rheumatology, St George's Healthcare NHS Trust, London, United Kingdom., Mitchell C; Department of Haematology, North Middlesex University Hospital NHS Trust, London, United Kingdom., Nguyen H; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Packham B; Thrombosis and Anticoagulation service, Royal Free London Hospital NHS Foundation Trust, London, United Kingdom., Paskell J; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Patel JP; Department of Haematological Medicine, King's College Hospital and Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Round C; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom., Sanna G; Louise Coote Lupus Unit, Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Zaidi A; Department of Haematology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, United Kingdom., Werring DJ; Stroke Research Centre, University College London Queen Square Institute of Neurology, London, United Kingdom., Isenberg D; Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom.; Department of Rheumatology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Cohen H; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Department of Haematology, Cancer Institute, University College London, London, United Kingdom.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2024 Jun 05; Vol. 8 (5), pp. 102468. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).